- Home
- TARS vs APLE Comparison
TARS vs APLE Comparison
Compare TARS & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | APLE |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TARS | APLE |
|---|---|---|
| Price | $81.11 | $11.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $76.56 | $14.17 |
| AVG Volume (30 Days) | 404.5K | ★ 2.6M |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 8.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | $366,100,000.00 | ★ $1,418,986,000.00 |
| Revenue This Year | $147.24 | $0.53 |
| Revenue Next Year | $53.11 | $2.22 |
| P/E Ratio | ★ N/A | $16.00 |
| Revenue Growth | ★ 182.44 | 0.57 |
| 52 Week Low | $38.51 | $10.44 |
| 52 Week High | $85.25 | $16.44 |
Technical Indicators
Market Signals| Indicator | TARS | APLE |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 52.66 |
| Support Level | $77.44 | $11.46 |
| Resistance Level | $85.25 | $11.94 |
| Average True Range (ATR) | 3.56 | 0.24 |
| MACD | -0.32 | -0.01 |
| Stochastic Oscillator | 55.84 | 55.12 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.